Related Experiment Videos
Substance P stabilizes interleukin-2 mRNA in activated Jurkat cells
1Laboratoire d'Immunologie Cellulaire et de Transplantation, CNRS Institut de Recherches Scientifiques sur le Cancer, Villejuif, France.
Journal of Neuroimmunology
|April 1, 1994
Summary
Substance P (SP) enhances interleukin-2 (IL-2) mRNA levels in activated T cells by increasing mRNA stability, not transcription. This finding reveals a post-transcriptional mechanism for SP
Area of Science:
- Immunology
- Molecular Biology
- Neuroscience
Background:
- Interleukin-2 (IL-2) is crucial for T cell activation and proliferation.
- Substance P (SP) is a neuropeptide that modulates immune responses.
- Previous studies indicated SP enhances IL-2 mRNA in co-stimulated Jurkat cells.
Purpose of the Study:
- To elucidate the mechanism behind SP-mediated enhancement of IL-2 mRNA.
- To determine if SP affects IL-2 gene transcription or mRNA stability.
Main Methods:
- Jurkat cells were co-stimulated with PHA+PMA and low-dose SP.
- Inhibition studies using cyclosporin A, actinomycin D, and cycloheximide.
- Nuclear run-on assays to assess gene transcription.
- mRNA degradation rate analysis following actinomycin D treatment.
Main Results:
- SP-augmented IL-2 mRNA signal was abrogated by early addition of inhibitors.
- Nuclear run-on assays confirmed SP does not affect IL-2 gene transcription.
- Actinomycin D treatment revealed a delayed degradation rate of IL-2 mRNA in SP-treated cells.
- This indicates a post-transcriptional mechanism involving mRNA stabilization.
Conclusions:
- SP enhances IL-2 production in activated T cells primarily by increasing IL-2 mRNA stability.
- The mechanism is post-transcriptional, affecting mRNA degradation rates.
- SP's role in immune modulation may involve regulating cytokine mRNA stability.